Encellin
Latest round
- Series A
Last raised
- Dec 2023
Total raised
- $16M
Investors
- 4
About Encellin
Encellin, founded in 2016, is headquartered in San Francisco, US, and specializes in advanced cell encapsulation technology. The CEO, Crystal Nyitray, is one of the co-founders, alongside Ronald Martell.Encellin specializes in the development of advanced therapeutic solutions, focusing on its core product, Encapsulated Cell Replacement Therapy (ENCRT). This innovative therapy addresses endocrine disorders by enhancing cell survival, allowing encapsulated cells to function as smart molecular factories that release therapeutics in response to physiological needs. Encellin targets type 1 diabetes, particularly addressing hypoglycemia, a significant clinical need.Encellin generates revenue through the commercialization of its ENCRT technology aimed at healthcare institutions that specialize in managing endocrine disorders. The company engages in B2B transactions with healthcare facilities that purchase its therapy for treatment protocols. Partnerships with hospitals and clinics are crucial, enabling direct distribution to patients with conditions like type 1 diabetes.
Who invested in Encellin
4 investors across 2 rounds
See all investors in Encellin
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Encellin
Who invested in Encellin?
Encellin has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Encellin raised?
Encellin has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Encellin last raise money?
Encellin's most recent round on record is a Series A, in Dec 2023.
What does Encellin do?
Encellin, founded in 2016, is headquartered in San Francisco, US, and specializes in advanced cell encapsulation technology.
Where is Encellin headquartered?
Encellin is headquartered in San Francisco, US.
Which VCs invest in companies like Encellin?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Encellin's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Encellin? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.